Baxter International (BAX): Price Target and June Short Interest Disclosure

Baxter International (BAX) stock is expected to deviate a maximum of $5.49 from the average target price of $48.83 for the short term period. 6 Street Experts have initiated coverage on the stock with the most promising target being $60 and the most muted being $46.

Baxter International (BAX), A reduction of 21,202,780 shares or 49% was observed in the short interest of Baxter International The interest on June 30,2016 came in at 22,101,171 shares and as per the average daily trading of 5,633,274 shares, the days to cover are 4. The reduced interest is 4% of the floated shares. The data of June 15,2016 put the interest at 43,303,951 shares. The information was released by Financial Industry Regulatory Authority, Inc (FINRA) on June 12th.

Also, Evercore ISI Group initiates coverage on Baxter International (NYSE:BAX) The brokerage firm has issued a Buy rating on the shares. The rating by the firm was issued on May 4, 2016.


Baxter International (NYSE:BAX): stock turned positive on Thursday. Though the stock opened at $47.09, the bulls momentum made the stock top out at $47.205 level for the day. The stock recorded a low of $46.74 and closed the trading day at $46.95, in the green by 0.28%. The total traded volume for the day was 2,907,113. The stock had closed at $46.82 in the previous days trading.

Baxter International Inc. (Baxter) is a diversified healthcare company. The Company operates in two segments: BioScience segment, which include three commercial franchises: Hemophilia, BioTherapeutics and BioSurgery, and Medical Products segment, which include four commercial franchises: Fluid Systems, Renal, Specialty Pharmaceuticals and BioPharma Solutions. Its BioScience processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions, and biosurgery products. Its Medical Products manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps and inhalation anesthetics. Its products are used in hospitals, kidney dialysis centers and nursing homes, among others.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.